Spent a year buying peptides, making mistakes, and pulling info from forum threads for basics that should've been in one place. Every guide was either oversimplified or quietly monetized through vendor affiliate links. The free ones are paid for by the vendors they recommend.
The cardiovascular markers were what caught my attention, too. 41% triglyceride reduction is massive compared to what you see with straight GLP-1s. The joint inflammation benefits make sense given the weight reduction, but the 75% pain improvement suggests direct anti-inflammatory pathways beyond mechanical relief alone.
Everyone's posting the 12mg retatrutide number from Lilly's TRIUMPH-1 results yesterday. 28.3% body weight loss at 80 weeks. 30.3% in the extension. Those are massive, and they deserve the attention.
I run reta myself, so I'm paying close attention to this data. The result I keep coming back to is actually the 4mg arm. 19% average weight loss with a discontinuation rate lower than placebo, and lower than the sugar pill group. Nearly 1-in-5 body weight reduction at the lowest dose tested, with fewer people dropping out than those taking nothing. For anyone titrating conservatively or prioritizing tolerability over chasing the maximum dose, that's the data point that matters most, and nobody is talking about it.
The twice-weekly reta split at 1mg is something I hadn't considered. I run mine as a single weekly dose, and the logic behind splitting it makes sense on paper: more consistent receptor activation and avoiding the trough before the next pin.
The TA-1 caught my attention too. Just ordered it myself, partly for immune modulation but specifically for the hepatic inflammation angle while running a heavier stack. I'm curious whether that was part of your reasoning or more of a secondary benefit you noticed along the way?
This is the conversation that matters more than the "which GLP-1 should I start" debate. My fiancée and I talked through our exit strategy before we started our protocol, specifically because the rebound data was so clear. Using the appetite suppression window to build habits that stick is the whole game. Glad to see actual research catching up to what the community has been figuring out by trial and error.
The part people are missing here: a standard purity test wouldn't have caught this. That vial would have come back at 98%+ purity because it IS pure, it's just pure BPC-157 instead of retatrutide. Purity tells you the compound is clean. Identity testing (HPLC fingerprint, mass spec) confirms that the compound is what the label says it is. Most people only check purity on a COA and assume they're good. This is exactly why identity confirmation from an independent lab matters before you inject anything.
100%...The uninformed crowd isn't taking the time to book appointments with their MD; they're ordering from the first vendor they find and figuring it out as they go (for better or for worse).
So there's a good chance the physicians getting these questions are sitting across from someone who's done their homework. They might know more about the compound's clinical and community reputation than the doctor does about its actual evidence base.
And honestly, if an MD is blindly prescribing treatments they haven't researched, that's a problem that existed well before peptides entered the picture.
Seeing numbers like this makes me glad I decided to pair my reta protocol with strength training 4-5 days a week and keep protein intake high from the start. I'd be curious what those percentages look like in a population that was actually lifting and eating 1g/lb+ protein throughout.
Very interesting. I just finished up a 10-day cycle of Epithalon myself, and the sleep improvement was hard to ignore. I was sleeping through the night without waking up, feeling sharp at 5:45 AM instead of dragging through the first hour, and the clarity carried through the rest of the day in a way I didn't expect. I'm pretty sure it complemented my CJC/Ipa stack too since the overnight GH pulse relies on quality deep sleep to do its job. Hadn't paired Epithalon with Pinealon before though. Might give that a go on my next cycle and see how the combination compares.
The sauna response shift makes sense. CJC-1295 raises your baseline GH, and elevated GH ramps up heat shock protein production on its own before you even sit down in the sauna. So you're basically walking in pre-loaded. I run CJC/Ipa nightly and noticed my recovery between training sessions got noticeably better before I even connected it to the GH timing. Curious if you saw any difference between the DAC and no-DAC versions on this, since DAC keeps GH elevated for days while no-DAC clears in about 30 minutes. That could change how the thermal response unfolds across repeated sessions.
My fiancée and I are kind of already doing a version of this. We run retatrutide weekly, and the glucagon receptor component seems to preserve lean mass better during a deficit than what I was seeing with semaglutide alone. I pair that with strength training 4-5 days a week, CJC/Ipamorelin before bed to support the overnight GH pulse for recovery, and IGF-1 LR3 post-workout to push the muscle repair side harder between sessions. The combination of retatrutide keeping the fat loss moving while the recovery compounds support what I'm doing in the gym has made a noticeable difference in how I hold onto strength during a cut. Excited to see what the trial data looks like when it catches up to what people are already experimenting with
Ozempic didn't just blow up because of clinical trials. It blew up because someone you follow posted a before-and-after. The science was already there for years. TikTok just made sure everyone found out at the same time without any of the context that should've come with it.
Now you've got people ordering research-grade semaglutide from vendors they found on Reddit, reconstituting it from a YouTube tutorial, and dosing based on whatever a comment section told them. The demand outpaced the education by about three years, and it shows.
Agreed, most people skip straight to GH compounds or GLP-1s and don't even know the nootropic peptides exist. I went with Adamax over standard Semax because the acetylated version crosses the blood-brain barrier more efficiently and lasts longer per dose. (Semax worked great, but I found Adamax to be a step up) It costs a bit more per vial and is harder to source, but for daily use, the convenience was worth the tradeoff.
Similar anxiety reduction, but through a completely different mechanism. Benzos bind directly to GABA-A receptors, and you feel it immediately. Selank modulates GABA tone more gradually without sedation, cognitive blunting, or dependency risk. The anxiolytic effect is more subtle, but it's there consistently without the crash or withdrawal curve. I wouldn't compare the strength to a benzo, but the functional result of being able to smile through a stressful situation is similar.
The patients-more-informed-than-their-docs dynamic is real, but it's more nuanced than it sounds. MDs have the research tools to look into any compound they want. The issue is that most of them have had zero reason to until their patients started walking in asking about BPC-157 by name. There's no CME course on research peptides and it's not like it's covered in residency. So we have physicians reverse-engineering the conversation, trying to figure out where the hell their patients picked this stuff up and whether there's anything to it. The demand for peptide education hit the consumer market years before the medical establishment had any framework to address it.
Running reta weekly for a few months now. The triple agonist profile is what pulled me in over tirz. The glucagon receptor piece is real, and it's what sets it apart. My fiancée noticed a resting HR bump early on that leveled out after a few weeks. The appetite suppression hits differently, too. With tirz it felt like food aversion. With reta it's more like genuine indifference to eating. She describes it the same way. Different mechanism, different subjective experience.
This is the part nobody prepares you for. Selank especially doesn't announce itself. I ran it for about three weeks before I realized my baseline stress response had just quietly shifted. No "moment," just a conversation that would have spiked my cortisol a month ago and didn't.
Adamax was similar. The cognitive effects crept in over days, not doses. I didn't feel sharper in the moment, but looked back after a couple of weeks and realized I had been more productive without trying to be.
The DAC version is the issue here. CJC-1295 with DAC has a half-life around 8 days, so instead of a short GH pulse that clears, you're getting a sustained baseline elevation that your body hasn't adapted to yet. That's what's disrupting sleep architecture.
Most people report it settling around day 5-7 as the body adjusts. If it doesn't, no-DAC CJC-1295 paired with Ipamorelin at bedtime gives you the GH pulse without the extended elevation. The pulse clears within about 30 minutes so sleep architecture stays intact.
Ran into the same thing and ended up on the no-DAC protocol for that reason.
@thegarybrecka The zone 2 approach works. I added BPC-157 to my recovery stack when I ramped up training volume last year. Made a huge difference in how fast I bounced back between sessions. Got my VO₂ tested at 52 ml/kg/min at 34. Not elite but decent baseline to work from
@hubermanlab The autonomic piece is huge. I noticed this running BPC-157 protocols. Better stress recovery directly improved how I handled difficult conversations. When your HRV stays stable under pressure, you actually have bandwidth to think before reacting